INS and polycystic ovary syndrome: Myo-inosito may act as an insulin sensitizer through insulin-resistant tissues, such as PCOS-endometrium and SMIT-1, provoking AMPK activation and elevated GLUT-4 levels, thereby increasing glucose uptake by human endometrial cells [124].